Manage episode 288897529 series 1103955
Guest: Petros Efthimiou, MD, FACR
Guest: Olga Petryna, MD, FACR
Is it time to connect the dots between systemic juvenile idiopathic arthritis (SJIA) and adult-onset Still’s disease (AOSD)? There is a growing recognition that SJIA and AOSD represent the same disease continuum with different ages of onset.1 Both conditions are rare autoinflammatory disorders of unknown etiology.1 In addition to Still’s disease rarity, patients present with varying symptoms and are diagnosed by exclusion of other diseases, which may result in a long time to proper care.2,3 A delay in diagnosis and failure to control disease activity can lead to severe and life-threatening complications.4 A multidisciplinary team effort and greater disease awareness are necessary to help expedite the therapeutic journey of patients with Still’s disease.5
Listen in to a discussion panel moderated by Christopher T. Ritchlin, MD with Petros Efthimiou, MD and Olga Petryna, MD as they have a conversation on the concept of the continuum of Still’s disease, its burden, and the patient journey.
This presentation is sponsored by Novartis Medical Affairs and all speakers have been compensated for their time.
- Vastert SJ, Jamilloux Y, Quartier P, et al. Anakinra in children and adults with Still’s disease. Rheumatology. 2019;58(suppl 6):vi9-vi22. doi:10.1093/rheumatology/kez350
- Efthimiou P. Diagnosis and management of adult onset ...